Bioheart, Inc.

Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients

Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients

Bioheart Announces Commercial Order for TGI 1200(tm) Adult Stem Cell Isolation System for Use in Chronic Limb Ischemia Patients

Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure

Bioheart Files for Reimbursement Approval in Switzerland for MyoCell(r) Myogenic Stem Cell Therapy for Heart Failure

Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure

Bioheart Announces Plans to Launch Clinical Trials in Europe and the USA for Second-generation Cell Therapy for Treating Advanced Heart Failure